Experience: Nathanael comes to SIRPant leveraging 20 years of experience in academic science and industrial research and development. Trained as an experimental immunologist and cell biologist, Nathanael began his research career in Becton Dickinson’s Molecular Diagnostics R&D division, resulting in 510(k) Premarket Notification and successful commercial launch of a clinical-grade molecular diagnostics device (BD ProbeTec ET). In graduate studies, he investigated cellular mechanisms of antigen processing by dendritic cells in the laboratory of Ira Mellman, PhD at Yale (now VP of Cancer Immunology at Genentech), followed by postdoctoral studies of cellular immunology in the laboratory of Max Cooper, MD (winner of the 2019 Lasker Award) at Emory. Following his postdoc, Nathanael worked in two biotech startup companies that were spun out of Emory (Haplomics, Inc and GeoVax, Inc) and was pivotal in raising $5.6M in non-dilutive funding for the firms. Prior to joining SIRPant, Nathanael held positions in academic technology transfer at Georgia State University and at Emory University.
Education:Nathanael received his MS, MPhil, and PhD in Immunobiology from Yale University. He earlier received a BS in Philosophy, Molecular Biology, Biochemistry, and Bioinformatics from Towson University.